Stay updated on Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s site revision identifier was updated from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T02:40:33.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page displays the completed BERENICE phase 2 breast cancer study record, including its treatment arms, eligibility criteria, locations, and safety and efficacy outcome measures.
    Difference
    100%
    Check dated 2026-11-11T01:44:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:05:01.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision number changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:08:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:17:29.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error with a header and a Home button, replacing the detailed study content and location information. Users can no longer access the trial details from this page.
    Difference
    19%
    Check dated 2026-09-23T00:36:27.000Z thumbnail image

Stay in the know with updates to Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.